Ligand validation:6I4F

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6I4F_BTB_A_405	0%	18%	0.374	0.306	2.98	0.65	5	-	0	0	100%	0.581
6I4K_BTB_A_404	10%	12%	0.18	0.683	3.03	1.12	4	1	0	0	100%	1
6I4E_BTB_A_408	8%	76%	0.177	0.64	0.5	0.45	-	-	1	0	100%	1
6I4J_BTB_A_406	8%	13%	0.275	0.74	2.88	1.11	5	-	0	0	100%	0.432
6I4D_BTB_A_406	1%	9%	0.313	0.432	3.87	0.74	5	-	0	0	100%	1
5O5D_BTB_B_504	100%	66%	0.02	0.995	0.94	0.38	2	-	0	0	100%	1
5O59_BTB_A_605	99%	76%	0.057	0.987	0.52	0.44	-	-	2	0	100%	1
2OB3_BTB_A_906	98%	13%	0.06	0.986	2.82	1.16	4	1	0	0	100%	1
9FZ6_BTB_C_902	98%	69%	0.07	0.989	0.83	0.37	-	-	1	0	100%	0.2
2OQL_BTB_B_701	95%	63%	0.066	0.969	0.66	0.75	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.